Drug Profile
SB 742510
Alternative Names: 742510; GSK-742510; SB-742510Latest Information Update: 25 Jan 2008
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Class Antibacterials
- Mechanism of Action Protein synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 25 Jan 2008 Discontinued - Phase-I for Bacterial infections in United Kingdom (PO)
- 30 Nov 2005 Phase-I clinical trials for Bacterial infections in United Kingdom (PO)